News | Published: Thursday, April 30, 2026
MedAxiom and AccuCode AI today announced the launch of AccuCode CV, an artificial intelligence (AI)-augmented cardiovascular coding engine that optimizes revenue integrity by improving accuracy, decreasing turnaround times and reducing costs.
This first-of-its-kind platform applies specialty-specific intelligence to the most complex and highest-risk cardiovascular coding scenarios, helping provider organizations improve coding accuracy, efficiency, quality and confidence—supporting revenue integrity while fitting into existing revenue cycle workflows.
Key benefits include:
AccuCode CV is delivered through a strategic partnership between MedAxiom and AccuCode AI, combining MedAxiom’s deep cardiovascular expertise with AccuCode AI’s pioneering technology.
“In cardiovascular care—one of the most complex and high-stakes areas of healthcare—coding precision is critical, and even small gaps can translate into meaningful revenue loss,” said Jerry Blackwell, MD, MBA, FACC, president and CEO of MedAxiom. “AccuCode CV uses AI-driven, cardiovascular-specific logic to augment coders, not replace them, with a human-in-the-loop process that keeps revenue cycle teams in control.”
“AccuCode CV applies AI through a proprietary, multi-step process that ingests documentation, interprets clinical context and validates code relationships against continuously updated guidelines,” said Nathan R. Myers, president and CEO of AccuCode AI. “That approach helps teams deliver more consistent cardiovascular coding—faster—while keeping coders at the center.”
To learn more and request a demo, visit AccuCodeCV.com.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.